Trial intelligence / Profile preview

Albumin in Cardiac Surgery with CPB

NCT03373318Phase 4Unknown

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Jan 2018
Primary completion
Aug 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of albumin (human) in acute kidney injury (AKI) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Incidence of Acute Renal Dysfunction Associated With Cardiac Surgery at 7 days. Status: unknown.

02

Drugs

albumin (human)
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT03373318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03373318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call